Novel Mechanisms of Resistance to Investigational Molecularly Targeted Drugs

Yakugaku Zasshi - Japan
doi 10.1248/yakushi.16-00229-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Mechanisms and Strategies to Overcome Resistance to Molecularly Targeted Therapy for Melanoma

Cancer
Cancer ResearchOncology
2017English

Heterogeneity and Plasticity of Human Breast Cancer Cells in Response to Molecularly-Targeted Drugs

Frontiers in Oncology
Cancer ResearchOncology
2019English

Resistance to Targeted Cancer Drugs Through Hepatocyte Growth Factor Signaling

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2014English

Analysis of Time-To-Onset of Interstitial Lung Disease After the Administration of Small Molecule Molecularly-Targeted Drugs

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2018English

Targeted Therapies in Cancer and Mechanisms of Resistance

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2014English

Hiv Resistance to Antiretroviral Drugs: Mechanisms, Genotypic and Phenotypic Resistance Testing in Clinical Practice

Acta Clinica Belgica
Medicine
2002English

Dissecting Mechanisms of Resistance to Targeted Drug Combination Therapy in Human Colorectal Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

A Novel Immunomodulatory and Molecularly Targeted Strategy for Refractory Hodgkin’s Lymphoma

Oncotarget
Oncology
2013English

Molecularly Targeted Therapy: Imatinib and Beyond

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy